Produktbild: Urothelial Carcinoma
Band 2684

Urothelial Carcinoma Methods and Protocols

Fr. 209.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

07.07.2024

Abbildungen

XI, 331 p. 55 illus., 51 illus. in color.

Herausgeber

Michèle J. Hoffmann + weitere

Verlag

Springer Us

Seitenzahl

331

Maße (L/B/H)

25.4/17.8/1.9 cm

Gewicht

648 g

Auflage

Second Edition 2023

Sprache

Englisch

ISBN

978-1-07-163293-2

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

07.07.2024

Abbildungen

XI, 331 p. 55 illus., 51 illus. in color.

Herausgeber

Verlag

Springer Us

Seitenzahl

331

Maße (L/B/H)

25.4/17.8/1.9 cm

Gewicht

648 g

Auflage

Second Edition 2023

Sprache

Englisch

ISBN

978-1-07-163293-2

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Urothelial Carcinoma

  • Scoring Systems for Immunohistochemistry in Urothelial Carcinoma.- A Panel-Based Method for the Reproduction of Distinct Molecular Subtype Classifications of Muscle-Invasive Urothelial Bladder Cancer.- Analysis of Mutational Signatures Using the
    mutSignatures
    R Library.- A Drug Repurposing Pipeline Based on Bladder Cancer Integrated Proteotranscriptomics Signatures.- Characterization of Native COMPASS Complex in Urothelial Carcinoma Cells by Size Exclusion Chromatography.- Reconstructing Phylogenetic Relationship in Bladder Cancer: A Methodological Overview.- Using Sister Chromatid Exchange Assay to Detect Homologous Recombination Deficiency in Epigenetically Deregulated Urothelial Carcinoma Cells.- Identification of STAG2 Mutant Bladder Cancers by Immunohistochemistry.- Genome-Wide CRISPR Screening for the Identification of Therapy-Resistance-Associated Genes in Urothelial Carcinoma.- Tissue Slice Culture and Analysis of Tumor-Associated Hyaluronan in Urothelial Carcinoma.- NGS-Based Tumor-Informed Analysis of Circulating Tumor DNA.- Considering the Effects of Modern Point-of-Care Urine Biomarker Assays in Follow-Up of Patients with High-Risk Non-Muscle Invasive Bladder Cancer.- Simplex Droplet Digital PCR Assays for the Detection of TERT Promoter Mutations in Urine Samples for the Non-Invasive Diagnosis of Urothelial Cancer.- Predictive Biomarkers of Response to Neoadjuvant Therapy in Muscle Invasive Bladder Cancer.- Assessment of PD-L1 Status in Urothelial Cancer.- Epigenetic Priming and Development of New Combination Therapy Approaches.- Evaluation of
    FGFR
    Alteration Status in Urothelial Tumors.- Antibody-Drug-Conjugates (ADC): A Novel Treatment Option in Urothelial Carcinoma.- Intravesical Infusion of Oncolytic Virus CG0070 in the Treatment of Bladder Cancer.- Analysis of ICAM-1 Expression on Bladder Carcinoma Cell Lines and Infectivity and Oncolysisby Coxsackie Virus A21.